Status:

COMPLETED

Pharmacist-Led Intervention to Improve TB Treatment Adherence

Lead Sponsor:

Universiti Sains Malaysia

Conditions:

Tuberculosis, Pulmonary

HIV Coinfection

Eligibility:

All Genders

19-70 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to compare the adherence of co-morbid patients in control and experimental group The main question\[s\]it aims to answer are: 1. To evaluate the impact of pharmaci...

Detailed Description

In 2019, tuberculosis (TB) remained the leading cause of death due to a single infectious pathogen. An estimated 10 million people had TB worldwide, with 1.2 million TB fatalities among Human immune d...

Eligibility Criteria

Inclusion

  • Men and women aged 18 years or more.
  • Newly bacteriologically confirmed TB case.

Exclusion

  • Pregnancy and any medical condition unrelated to TB

Key Trial Info

Start Date :

September 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2025

Estimated Enrollment :

383 Patients enrolled

Trial Details

Trial ID

NCT06608069

Start Date

September 1 2023

End Date

February 1 2025

Last Update

August 7 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Pulau Pinang

George Town, Malaysia, 11800

2

Universiti Sains Malaysia

George Town, Malaysia, 11800

Pharmacist-Led Intervention to Improve TB Treatment Adherence | DecenTrialz